Intellia Therapeutics Cash Flow Statement (2015-2026) | NTLA

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-1043.28M-673.57M-82.04M-348.57M-203.53M-220.59M-108.56M-159.36M-188.31M-158.19M-163.35M-128.99M-142.44M-143.90M-126.49M-254.93M-118.23M-222.41M-92.28M-192.17M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
10.61M15.41M14.56M18.49M23.07M25.21M0.28M27.25M36.40M35.35M35.04M34.18M40.86M39.62M-1.83M21.84M22.04M7.90M16.74M10.50M
Gains from Investment Securities (Quarter)
0.42M-0.17M7.81M5.43M0.10M
Cash from Operations (Quarter)
-52.98M-65.02M-54.65M-79.80M-85.09M-78.53M-89.87M-109.33M-90.32M-101.38M-93.05M-120.66M-58.19M-84.84M-85.19M-148.93M-99.62M-76.90M-69.28M-117.35M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.66M-2.10M-2.63M-2.43M-2.00M-0.82M1.25M4.57M7.10M7.92M6.31M5.29M4.65M4.28M3.60M2.28M1.67M1.08M0.83M0.54M
Amortization of Deferred Charges (Quarter)
3.63M
Depreciation & Amortization (CF) (Quarter)
1.63M1.79M1.89M1.75M1.84M1.95M2.06M2.05M2.17M2.29M2.47M2.50M2.60M2.60M2.57M2.50M2.50M2.40M2.37M2.20M
Change in Working Capital
Change in Receivables (Quarter)
1.04M0.50M-0.46M-0.23M1.05M1.17M-0.26M1.14M0.15M1.43M29.96M-0.03M-24.10M-3.47M-0.34M1.99M0.85M-0.30M-1.58M-0.34M
Change in Account Payables (Quarter)
-1.69M0.74M2.40M-0.06M-3.65M-1.62M0.75M1.17M5.12M-7.71M3.94M5.57M5.35M-5.55M1.44M-1.87M-2.56M3.46M6.96M-1.42M
Change in Accured Expenses (Quarter)
14.72M-11.30M18.43M-3.72M3.00M13.57M3.07M-17.39M4.87M9.52M9.03M-22.40M1.85M6.22M3.95M-14.41M0.83M-0.71M9.03M-11.95M
Other Working Capital Changes (Quarter)
-5.62M-5.81M-14.37M-13.99M-16.10M-16.64M-16.73M-14.57M-14.35M-8.79M34.93M-5.37M-5.39M-5.47M-5.84M-5.09M-4.13M-4.91M-13.98M-6.66M
Investing Activities
Capital Expenditures (Quarter)
4.45M4.54M2.87M3.72M0.03M-1.57M-0.56M3.52M4.61M4.33M-10.94M2.51M-1.88M-0.26M0.20M0.08M-0.08M1.00M0.13M
Change in Acquisitions & Divestments (Quarter)
73.30M192.49M94.61M93.73M130.85M212.80M210.19M263.62M213.05M213.20M197.23M267.96M277.63M199.67M321.65M178.27M162.75M115.94M94.71M113.35M
Cash from Investing Activities (Quarter)
33.26M-399.38M-159.12M47.47M95.34M47.64M-30.15M-122.25M-34.54M79.50M45.94M5.90M-24.19M-7.71M151.56M94.33M106.91M-0.74M27.53M66.31M
Financing Activities
Other financing activities (Quarter)
-13.13M39.66M1.23M8.44M4.83M-12.19M13.45M0.76M0.47M0.83M1.88M1.96M-0.29M1.32M1.24M-1.14M0.62M
Change in Capital Stock
Shares Issued (Quarter)
2.82M1.98M6.31M2.43M2.52M2.86M5.47M5.91M5.90M3.85M5.46M4.26M4.29M5.48M5.41M5.90M4.18M4.09M5.17M5.63M
Net Equity Issued and Repurchased (Quarter)
603.06M400.00M-361.12M23.25M337.86M1.47M14.72M103.61M58.03M36.37M80.50M2.00M13.70M114.47M750.00M
Misc.
Cash from Financing Activities (Quarter)
7.13M668.68M2.28M47.32M5.89M23.98M505.76M2.22M2.52M19.10M106.48M59.99M41.25M82.19M2.32M14.65M114.86M1.98M33.57M
Change in Cash (Quarter)
-12.59M204.28M-211.49M14.99M16.15M-6.91M385.74M-229.35M-122.34M-2.78M59.37M-54.77M-41.13M-10.35M68.69M-54.60M21.94M37.22M-39.77M-17.47M
Free Cash Flow (Quarter)
-57.43M-69.56M-57.52M-83.52M-85.12M-76.96M-89.31M-112.85M-94.93M-105.71M-82.11M-123.17M-56.31M-84.58M-85.40M-149.01M-99.54M-77.90M-69.41M-117.35M
Net Cash Flow (Quarter)
-12.59M204.28M-211.49M14.99M16.15M-6.91M385.74M-229.35M-122.34M-2.78M59.37M-54.77M-41.13M-10.35M68.69M-54.60M21.94M37.22M-39.77M-17.47M